Gensco® Pharma is a specialty pharmaceutical company established in 2009, which concentrates on the research, development, and marketing of transdermal prescription products. The company takes pride in its innovation of non-narcotic transdermal analgesic gels through patented drug delivery solutions. This is facilitated by their airless, closed-system, metered dose technology, MDose™, ensuring precise medication dispensing and optimized results with minimal side effects. Gensco® Pharma positions itself as a healthcare partner, committed to continuously pursuing novel and effective therapies to enhance health. As healthcare visionaries, the company embodies boundless potential and promises.
There is no investment information
No recent news or press coverage available for Gensco Pharma.